2008
|
Sign up to set email alerts
Synthesis and Antibacterial Activity of a New Series of 2,3,5,7-Substituted-pyrido[2,3-d]pyrimidin-4(3H)-one Derivatives
Search citation statements
Order By: Relevance
Paper Sections
Select...
11
1
0
0
Citation Types
0
5
0
0
Year Published
Range
2009
20092026
2026Publication Types
Select...
11
1
Relationship
0
12
Authors
Journals
Cited by 12 publications
(5 citation statements)
References 32 publications
0
5
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The ortho-fusion of the pyridine and pyrimidine rings yields pyridopyrimidines, which are known to exist in a number of classes of potential isomeric forms, including derivatives of pyridopyrimidines. The numerous pharmacological uses for analogues of pyrido [2,3-d]pyrimidines involve chemotherapy drugs, 44,45 antimicrobial agents, [46][47][48][49] antiviral agents, 50,51 antioxidant agents, 21 antituberculosis agents, 52 antidiabetic agents, 53 and anticholinesterase agents, 54 which have drawn signicant attention from medicinal chemists.…”
Section: Basant Farag
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The ortho-fusion of the pyridine and pyrimidine rings yields pyridopyrimidines, which are known to exist in a number of classes of potential isomeric forms, including derivatives of pyridopyrimidines. The numerous pharmacological uses for analogues of pyrido [2,3-d]pyrimidines involve chemotherapy drugs, 44,45 antimicrobial agents, [46][47][48][49] antiviral agents, 50,51 antioxidant agents, 21 antituberculosis agents, 52 antidiabetic agents, 53 and anticholinesterase agents, 54 which have drawn signicant attention from medicinal chemists.…”
Section: Basant Farag
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…All the resultant compounds (288) were examined for antibacterial activity against Gram +ve and Gram −ve bacteria. 280 …”
Section: Orthoester Reactions Under Solvent-free Conditions
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…For example, this heterocyclic structural motif is present in AZD8055 (A), a selective ATP-competitive PI3K-Akt-mTOR signaling pathway inhibitor used for the treatment of antitumor, piritrexim (B), a lipid-soluble inhibitor of dihydrofolate reductase (DHFR) that displays high potency for the treatment of metastatic urothelial cancer, and pyrido[2,3- d ]pyrimidine derivative C that is a hepatitis C virus replicon inhibitor (Figure ). Also, substances that possess the pyrido[2,3- d ]pyrimidine framework have other interesting biological properties such as anticardiovascular, anti-inflammatory, antibacterial, , and anti-Parkinson’s activities . The few methods thus far devised to prepare these substances involve condensation reactions of pyridine or pyrimidine (Scheme ), which are only applied with difficulty when diversified substitution patterns are required.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The ortho-fusion of the pyridine and pyrimidine rings yields pyridopyrimidines, which are known to exist in a number of classes of potential isomeric forms, including derivatives of pyridopyrimidines. The numerous pharmacological uses for analogues of pyrido [2,3-d]pyrimidines involve chemotherapy drugs, 44,45 antimicrobial agents, [46][47][48][49] antiviral agents, 50,51 antioxidant agents, 21 antituberculosis agents, 52 antidiabetic agents, 53 and anticholinesterase agents, 54 which have drawn signicant attention from medicinal chemists.…”
Section: Basant Farag
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…All the resultant compounds (288) were examined for antibacterial activity against Gram +ve and Gram −ve bacteria. 280 …”
Section: Orthoester Reactions Under Solvent-free Conditions
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…For example, this heterocyclic structural motif is present in AZD8055 (A), a selective ATP-competitive PI3K-Akt-mTOR signaling pathway inhibitor used for the treatment of antitumor, piritrexim (B), a lipid-soluble inhibitor of dihydrofolate reductase (DHFR) that displays high potency for the treatment of metastatic urothelial cancer, and pyrido[2,3- d ]pyrimidine derivative C that is a hepatitis C virus replicon inhibitor (Figure ). Also, substances that possess the pyrido[2,3- d ]pyrimidine framework have other interesting biological properties such as anticardiovascular, anti-inflammatory, antibacterial, , and anti-Parkinson’s activities . The few methods thus far devised to prepare these substances involve condensation reactions of pyridine or pyrimidine (Scheme ), which are only applied with difficulty when diversified substitution patterns are required.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…The ortho-fusion of the pyridine and pyrimidine rings yields pyridopyrimidines, which are known to exist in a number of classes of potential isomeric forms, including derivatives of pyridopyrimidines. The numerous pharmacological uses for analogues of pyrido [2,3-d]pyrimidines involve chemotherapy drugs, 44,45 antimicrobial agents, [46][47][48][49] antiviral agents, 50,51 antioxidant agents, 21 antituberculosis agents, 52 antidiabetic agents, 53 and anticholinesterase agents, 54 which have drawn signicant attention from medicinal chemists.…”
Section: Basant Farag
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…All the resultant compounds (288) were examined for antibacterial activity against Gram +ve and Gram −ve bacteria. 280 …”
Section: Orthoester Reactions Under Solvent-free Conditions
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…For example, this heterocyclic structural motif is present in AZD8055 (A), a selective ATP-competitive PI3K-Akt-mTOR signaling pathway inhibitor used for the treatment of antitumor, piritrexim (B), a lipid-soluble inhibitor of dihydrofolate reductase (DHFR) that displays high potency for the treatment of metastatic urothelial cancer, and pyrido[2,3- d ]pyrimidine derivative C that is a hepatitis C virus replicon inhibitor (Figure ). Also, substances that possess the pyrido[2,3- d ]pyrimidine framework have other interesting biological properties such as anticardiovascular, anti-inflammatory, antibacterial, , and anti-Parkinson’s activities . The few methods thus far devised to prepare these substances involve condensation reactions of pyridine or pyrimidine (Scheme ), which are only applied with difficulty when diversified substitution patterns are required.…”
mentioning
confidence: 99%